Streptococcus pneumoniae, a common human pathogen, colonizes the nasopharynx and causes diseases including acute otitis media (AOM). Herein, pneumococcal serotype distributions in children before and after PCV7 vaccination and in patients with pneumococcal disease in Siberian Russia (Krasnoyarsk) are reported. Analyses included antimicrobial susceptibility testing, sequence typing (ST), pulsed field gel electrophoresis, virulence-related surface protein gene (VSG) typing with novel primers and structural analysis by scanning electron microscopy. In healthy children (HC) prior to administration of PCV7, drug-susceptible serotype23F/ST1500 was a major pneumococcal genotype. In the PCV7 trial, multidrug-resistant serotype19A/ST320 emerged in vaccinees after PCV7, exhibiting a PCV7-induced serotype replacement. Multidrug-resistant serotype19A/ST320 was evident in patients with AOM. Community-acquired pneumonia (CAP) isolates showed genetic similarities to the AOM (ST320) genotype, constituting a common non-invasive AOM-CAP group. In contrast, meningitis isolates were more divergent. Overall, 25 ST types were identified; five (20%) of which were Krasnoyarsk-native. Regarding VSGs, PI-1 (rlrA/rrgB), PI-2 (pitA/B), psrP and cbpA were present at 54.3%, 38.6%, 48.6%, and 95.7%, respectively, with two major VSG content types, PI-1 
wire (pilus) structures in colonies. ST1016 (PI-1 À /PI-2 À ) in HC had HEp-2 cell-adherent pili. These results suggest that serotype19A/ST320 and related genotypes, with the VSG content type PI-1 þ /PI-2 þ /psrP À /cbpA þ , emerged in vaccinees after PCV7 in Siberia, accompanying diseases in nonvaccinated children, and that some genotypes (serotypes19A/ST320 and 18/ST1016) produced novel pneumococcal structures, predicting their roles in colony formation and adherence.
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Streptococcus pneumoniae, a leading bacterial human pathogen, has high morbidity and mortality rates (1) . It colonizes the nasopharynx, particularly in children (1) (2) (3) , nasopharyngeal colonization proceeding to development of pneumococcal diseases (1, (4) (5) (6) . Invasive infections include bacteremia and meningitis; these are mostly reported in children aged <2 years (1) . Mucosal/ non-invasive infections include non-bacteremic pneumonia, AOM and sinusitis, which are less severe, but very common health issues (1, 6, 7) . The most frequent S. pneumoniae infection is AOM, including patients in whom it is a complication of influenza (8) .
The virulence factors of S. pneumoniae include capsular polysaccharides (9) (10) (11) (12) , which represent the serotypes of S. pneumoniae; more than 90 serotypes have been identified (5, 11, 13) . A polysaccharide capsule plays a key role in nasopharyngeal colonization and immune evasion from phagocytosis or complement factor binding (10, 12, 13) , and is the target of PCVs such as PCV7 and PCV13 (6, (11) (12) (13) (14) .
Regarding pneumococcal surface proteins (9) (10) (11) (12) , two types of pneumococcal pili, PI-1 and PI-2, have been identified. The major backbone subunit of PI-1 is the RrgB protein, the expression of which (gene, rrgB) is regulated by the rlrA gene (15) (16) (17) (18) . PI-1 is present only in certain pneumococcal CCs. The backbone protein of PI-2 is considered to be PitB (gene, pitB); the PI-2 islet carries a second pilus gene pitA, which has a premature stop codon (19, 20) . Although PI-2 may be more widely distributed, it is weakly expressed (21) .
The largest pneumococcal surface protein, PsrP, varies in size (22, 23) . PsrP promotes pneumococcal adherence to nasopharyngeal epithelial cells and lung cells and contributes to robust formation of biofilms (9, 10, 22, (24) (25) (26) . CbpA plays a role in adherence, colonization and immune evasion from complement attack and opsonophagocytosis (9, 10, 27) .
S. pneumoniae forms biofilms during colonization of the nasopharynx and during diseases such as chronic otitis media and pneumonia (28, 29) . Biofilms may endow pneumococci with reduced susceptibility to antimicrobial agents or resistance to immune recognition (10, 28) . They may also contribute to colonization and persistence on the mucosa, but with altered virulence (24) or regulation (29) .
S. pneumoniae serotypes/serogroups have been investigated in Russia (30, 31) ; three PCVs, PCV7, PCV10 and PCV13, have been registered for children. The molecular characteristics of S. pneumoniae have not yet been reported in Siberian Russia (Krasnoyarsk), which is located between the European and Far Eastern regions. We herein isolated and characterized S. pneumoniae in children before and after PCV7 vaccination and also in children with pneumococcal diseases in Krasnoyarsk. Because certain surface protein genes are highly variable, we designed PCR primers based on available pooled S. pneumoniae genome information. We also investigated pneumococcal surface ultrastructures using SEM.
MATERIALS AND METHODS

PCV7 vaccination, patients and ethics statement
None of the children in the present PCV7 trial had previously received S. pneumoniae vaccines. Furthermore, none of them received PCV7 before they presented with pneumococcal diseases. This study was approved by the Ethics Committee of Krasnoyarsk State Medical University (Protocol No. 2/2011). Informed consent was obtained from the parents or legal representatives of each child.
Typing of S. pneumoniae
Capsular typing was achieved by PCR, as previously described (32) . STs were examined by PCR and sequencing, according to the MLST website (33) and CCs were analyzed using eBURST (34).
Susceptibility testing
The MICs of antimicrobial agents were measured by an agar dilution method using Mueller-Hinton agar (Difco, Sparks, MD, USA) supplemented with 5% sheep blood (Nippon Bio-Test Laboratories, Tokyo, Japan), as described previously (35, 36) . MICs of antimicrobial agents (including penicillin) for S. pneumoniae ATCC49619 (reference strain) that were obtained by the agar dilution method were consistent with those described by the CLSI (36) . A disc method using antimicrobial agent discs (Becton Dickinson, Franklin Lakes, NJ, USA) was also employed (in initial susceptibility testing); oxacillin was used for penicillin in the disc method (36) . Breakpoints for drug resistance were those described by CLSI (36 
Clonal analysis of S. pneumoniae
In PFGE analysis, bacterial DNA was digested with SmaI and electrophoresed in 1.2% agarose, as described previously (37) .
Surface protein gene analysis by PCR
The four VSGs, PI-1, PI-2, psrP and cbpA, were analyzed by PCR. The primers used for PCR are summarized in Table S1 (21, 38, 39) and are those reported by others plus those designed in the present study based on available pooled S. pneumoniae genome information (Fig. S1) (20, 21, 40, 41) . The PCR conditions employed were initial denaturation at 95°C for 5 min, denaturation cycling at 95°C for 20 s, annealing at 52°C-55°C (depending on the Tm of primers used) for 30 s, extension at 68°C for 1 min (35 cycles), and a final extension at 68°C for 10 min, as described previously (39) . PCR products were sequenced to confirm the target gene sequence.
Phylogenetic and homology analyses
A phylogenetic analysis was conducted in MEGA6 using the maximum likelihood method based on the Kimura 2-parameter model; the reliability of the tree was estimated with a bootstrap analysis by 1000 replicates (42, 43) . A homology analysis was performed using BLAST software (44) and DNAMAN (45) .
Analysis of S. pneumoniae ultrastructures
To investigate bacterial surface structures, S. pneumoniae was grown on trypticase soy agar supplemented with 5% sheep blood (Becton Dickinson, Tokyo) at 37°C for 12-18 hr. Blood agar-block pieces were fixed, dehydrated, critical-point dried, coated with gold-palladium and assessed using a SEM, as described previously (46) . S. pneumoniae ATCC49619 was used as a control strain.
Adherence assay
Regarding adherence to HEp-2 cells (a human epithelial cell line originating from human laryngeal carcinoma), S. pneumoniae cells, grown on blood agar plates as above, were added to HEp-2 cells on plastic coverslips at 37°C for 2 hr, after which HEp-2 cell samples were assessed by SEM, as described previously (47) . S. pneumoniae ATCC49619 was used as a control strain.
Statistical analysis
Data were statistically analyzed using Fisher's exact test. The level of significance was defined as P < 0.05.
RESULTS
First PCV7 trial in Krasnoyarsk
One hundred and eighty-three healthy children (aged 0-5 years; mean age, 3.7 years; 0.3% of the total population of approximately 70,000 children of corresponding ages in Krasnoyarsk), none of whom had any infectious diseases at the time of examination, were selected by pediatricians in 2011. Nasopharyngeal swabs were obtained from these healthy children prior to administration of PCV7 in 2011; these swabs yielded 93 S. pneumoniae strains. All 183 HC were then vaccinated with PCV7 in 2011. In 2013, nasopharyngeal specimens were obtained from 171 HIC; these swabs yielded 54 S. pneumoniae strains. The HIC did not receive antibiotics prior to the nasal swabs being obtained and S. pneumoniae isolated.
S. pneumoniae carriage rates in HC and HIC were 50.8% (93/183) and 31.6% (54/171), respectively, this being a significant decrease in carrier rate after vaccination (p < 0.01). S. pneumoniae carriage rates did not differ significantly between kindergartenattending and non-attending children; most of the latter group of children had kindergarten-or school-attending siblings. Although vaccinees included residents of orphanages, no significant bias in carriage rates was observed between these orphans and other children because the orphans were in various orphanages located in different parts of Krasnoyarsk and were thus not members of a closed group. PCV7 serotypes in HC, such as 23F and 19F, were controlled by administration of PCV7; the number of serotypes/serogroups changed from eight (23F, 19F, 15AF, 23A, 14, 6, 35AC/42 and 18) to five (19A, 15BC, 6, 35AC/42 and 11AD) (Fig. 1) , but with prominent emergence of the non-PCV7 serotype 19A, confirming PCV7-related serotype replacement over the two-year period (48) (49) (50) . There were no non-encapsulated strains.
Because the entire study group in Krasnoyarsk was disbanded in 2012, this trial yielded no accurate data concerning vaccine efficacy regarding disease prevention. Regarding HC, the serotype coverage rates of PCV7 and PCV13 were 62.5%; in the present study, we examined serogroup 6 only (not 6A, 6B or 6C).
S. pneumoniae strains were also isolated from patients with pneumococcal diseases in three hospitals in Krasnoyarsk. The most prevalent pathogen of AOM, a common disease in children, was S. pneumoniae, which accounted for 32.6% of bacterial infections (23.8% of all cases) in Krasnoyarsk; this is consistent with previous findings (51 -54) . The isolated strains included 12 strains from middle ear fluids of 12 patients with AOM (aged 8 months to 9 years; mean age, 2.0 years) in 2014 and 2016, four strains from aspirated sputum of four patients with CAP (aged 2 Table 1 . Regarding patients, the serotype coverage rates of PCV7 and PCV13 were 62.5% and 100%, respectively.
Molecular characterization of S. pneumoniae
Twenty-three HC and 27 HIC isolates were randomly selected from each serotype/serogroup and their molecular charcateristics examined; resultant data are summarized in Table 1 . There were 11 ST types among the HC strains, the most prevalent being ST1500 (CC30)/serotype23F, which was drug-susceptible, whereas there were eight ST types among the HIC strains, the most prevalent being ST320(CC320)/ serotype19A, which was MDR. MDR was observed only in CC320 and its related CC271 and CC236.
There were seven ST types among AOM strains (n ¼ 27), the most prevalent being ST320/serotype19A, which was MDR (Table 1 ). CAP strains (n ¼ 4) included CC271 and CC320; they were all MDR (Table 1) . Meningitis strains (n ¼ 4) were diverse in CCs; only CC320 was MDR (Table 1) .
Regarding ST320/serotype19A strains, seven of the 10 HIC strains and two of the three AOM strains examined by PFGE (Fig. 2a) exhibited identical PFGE patterns (designated a1), two HIC strains showing only a oneband difference (PFGE pattern a2), indicating the same clone (ST320/19A Kras ). Regarding CAP strains (Fig. 2b) , two strains (ST7915/serotype19A) showed the PFGE a1 pattern, whereas the remaining two (ST2323/serotype19F) showed a two-band difference (PFGE pattern a3) and belonged to the same clone (non-invasive group) as ST320/19A Kras . In contrast, meningitis strains exhibited divergent PFGE patterns (Fig. 2b) .
Regarding VSGs (Tables 1 and S2 ), when the 70 strains (Table 1) were examined, PI-1, PI-2, psrP and cbpA were found to be present at 54.3% (38/70), 38.6% (27/70), 48.6% (34/70), and 95.7% (67/70), respectively ( Table 2 ). There were two major SVG content types, PI-1
the latter correlated with a non-invasive AOM and CAP group (Table 2) , mainly in association with CC320 and CC271 (Fig. 3) . In contrast, the PI-1 À /PI-2 À /psrP þ /cbpA þ type correlated with the colonization of HC (Table 2) , mainly in association with CC30 and CC1025 (Fig. 3) .
Ultrastructures of S. pneumoniae
S. pneumoniae cells grown on blood agar were analyzed by SEM (Fig. 4) . When ST320/19A Kras -a1 (Fig. 2a) was examined, very long PWS were found in the colonies (Fig. 4a, b) . PWS were > 4 mm in length, gently curved, and had the appearance of whips or even peritrichous flagella; no short pili were observed. In the case of ST320/19A Kras -a2 (Fig. 2a) , S. pneumoniae cells in colonies only had shorter, straight, thin pili (Fig. 4c) . S. pneumoniae ATCC49619, used as a control strain, showed no PWS or obvious pili.
When S. pneumoniae in HC (Table 1) was examined in the HEp-2 cell assay (Fig. 5) , each single cell of ST1016/ serogroup18 (PI-1 À /PI-2 À ) was clearly piliated (Fig. 5a , arrow) and showed pili-mediated adherence (Fig. 5c) ; these pili (PAP) were often observed to form a ring at the position of cell septation sites ( Fig. 5d; arrow) . In contrast, no obvious pili-mediated adherence to HEp-2 cells was found for other S. pneumoniae in HC. S. pneumoniae belonging to ST320/ 19A Kras -a1 and a2 (Fig. 2a) and S. pneumoniae ATCC49619, used as a control strain, also showed no adherence to HEp-2 cells (data not shown).
DISCUSSION
In Krasnoyarsk, Siberian Russia, S. pneumoniae found to be colonizing healthy children (HC and HIC) included five novel ST types (ST8636, ST9247, ST9248, ST9249 and ST9250), representing Krasnoyarsk (Siberia)-local characteristics. S. pneumoniae in HC, examined in 2011, was mostly drug-susceptible, the most prevalent type being ST1500(CC30)/serotype23F with the SVG content type PI-1
The genotype psrP þ in HC is consistent with previous reports that PsrP promotes nasopharyngeal pneumococcal colonization (25, 55) . Although the serotypes were divergent, ST1500 was also a minor constituent of isolates from patients with AOM (between 2014 and 2016). CC30 is 
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not a global CC and, to the best of our knowledge, there is currently no information available on its genome. A few of the S. pneumoniae colonizing HC were MDR; ST236(CC236)/serotype19F and ST2323(CC271)/serotype19F were found to be related to MDR ST320 (CC320)/serotype19A (Figs. S2, S3 ). The first small-scale PCV7 trial in Krasnoyarsk resulted in serotype replacement with global, MDR ST320/serotype19A (Fig. S3) , which is consistent with previous findings (48 -50, 56-58) . Nasopharyngeal colonization precedes any type of pneumococcal disease, including AOM. PCV7 primarily increases serotype 19A carriage and, as a consequence, increases the rate of 19A-related pneumococcal disease. In the present study, because HIC did not receive antibiotics prior to isolation of S. pneumoniae, the underlying mechanism or source , P < 0.01 Ã1 , P < 0.01
of emergence in HIC of ST320/serotype19A, which appeared to have a high fitness cost from MDR (59), currently remains unknown. ST320/serotype19A may have superior fitness to the "empty" nasopharyngeal niche in HIC. Moreover, in the present study we did not examine carriage in healthy children who had not been vaccinated with PCV7. Of the four VSGs, PI-1, PI-2, psrP and cbpA are located at a region (named rlrA pathogenicity islet or PI-1 islet) flanked by IS1167 (21, 60) , the PI-2 islet (20, 21), a pathogenicity island (22, 26, 61) , and a chromosomal core (in some cases, a region flanked by IS) (41, 62) , respectively. Certain VSGs had highly variable sequences, confirming previous findings (41) . Therefore, we improved the PCR primers and also attempted to use multiple primers for each PCR target. As a result, the low yields (for example, 55.7%-positive) in PCR using previously reported primers increased to high yields (for example, 94.3%) in the present study, reaching the level predicted on the basis of pooled genome sequences previously reported. However, a limitation of the present study was that we only analyzed four VSG targets and the disease groups studied, particularly CAP and meningitis, were small. Results of PFGE analysis and VSG content typing strongly suggest that AOM and CAP isolates are a common non-invasive group. The results of the present study also indicate that the surface proteins PitA and PitB are protected from attacks by host immunity because, even though rrgB, psrP and cbpA were highly variable, pitA and pitB were conserved.
In previous studies, we found that it was possible to demonstrate the unique surface structures of bacterial pathogens in colonies (at high cell densities) using SEM (46, 63, 64) . In the present study, we found that the major epidemiological clone (PFGE a1 type) of ST320/ serotype19A, associated with AOM, formed novel PWS in colonies; the PWS were unusually long, curved, and did not have the morphological appearance of pili, instead resembling whips or peritrichial flagella. AOMassociated ST320/serotype19A was PI-1 þ /PI-2 þ . The molecular and genetic features of PWS are currently being investigated. Type IV pili, very long pilus structures, have been investigated in gram-negative bacteria (65) . We also noted heavy biofilm formation and PSS in colonies of AOM-associated ST320/serotype19A (Figs. S4, S5 ). At high cell densities in colonies, these structures may adhere together to make rigid, noninvasive clinical foci on the mucosa, thus facilitating successful colonization and infection.
We also found that, in HC, ST1016/serogroup18 formed HEp-2 cell-adherent pili. Given that ST1016/ serogroup18 was PI-1 À /PI-2 À , PAP represent the third most frequent adherent pili in S. pneumoniae that play roles in colonization of HC.
In conclusion, we, for the first time, here report changes in pneumococcal serotype distribution in a cohort of children after PCV7 vaccination and in a small group of patients with pneumococcal disease in Krasnoyarsk, Siberian Russia. We found Krasnoyarsk (Siberia)-local clones. The most prevalent S. pneumoniae in the nasopharyngeal niche of HC was drugsusceptible ST1500/serotype23F with the VSG content type PI-1 À /PI-2 À /psrP þ /cbpA þ , suggesting that PsrP plays an important role in nasopharyngeal colonization. PCV7 increased the carriage in HIC of MDR serotype 19A/ST320, with PI-1 þ /PI-2 þ /psrP -/cbpA þ and, as a consequence, increased the rate of 19A/ ST320-related non-invasive pneumococcal disease, including AOM, in non-vaccinated children. The major epidemiological clone of ST320/serotype19A (PI-1 þ /PI-2 þ ) formed novel PWS in colonies, most likely for rigid colonization and immune evasion in the middle ear. ST1016/serogroup18 (PI-1 À /PI-2 À ) in HC formed novel HEp-2 cell-adherent pili, possibly for nasopharyngeal colonization and was the third most frequent pneumococcal pili. 
